Daiken Medical Co., Ltd. provided non-consolidated earnings guidance for the year ending March 31, 2023. For the year ending March 31, 2023, the company expects to report net sales of ¥9,000 million, operating profit of ¥1,200 million, and profit of ¥840 million or ¥29.24 per share.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
545 JPY | +1.49% |
|
-0.18% | +6.24% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.24% | 95.39M | |
+75.67% | 12.57B | |
-25.94% | 6.96B | |
-5.03% | 5.69B | |
+5.61% | 5.02B | |
-15.92% | 4.76B | |
+15.98% | 4.1B | |
-16.16% | 3.94B | |
-18.01% | 3B | |
-0.87% | 1.99B |
- Stock Market
- Equities
- 7775 Stock
- News Daiken Medical Co., Ltd.
- Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2023